Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Adherium Ltd. ( (AU:ADR) ) is now available.
Adherium Limited is launching a partially underwritten accelerated non-renounceable entitlement offer to raise up to $4 million. The funds will be used to expand operations in the U.S., including hiring employees and contractors, recruiting a CEO, and general working capital. The initiative has received strong backing from major shareholders and venture capital funds, indicating confidence in Adherium’s growth strategy and its potential impact on the respiratory care market.
More about Adherium Ltd.
Adherium Limited is a leading digital health company specializing in respiratory care through its Hailie® Smartinhalers. These devices improve patient adherence, reduce hospitalizations, and lower healthcare costs by providing real-time remote monitoring. The company’s technology, which is FDA-cleared, covers 80% of the U.S. inhaler market, offering a significant competitive advantage. Adherium has commercial agreements with major healthcare providers and is actively expanding its patient base.
Average Trading Volume: 107,044
Technical Sentiment Signal: Sell
Current Market Cap: A$5.31M
Learn more about ADR stock on TipRanks’ Stock Analysis page.